We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Gets Rights for OTC Orlistat Outside U.S.
GSK Gets Rights for OTC Orlistat Outside U.S.
February 20, 2007
GlaxoSmithKline (GSK) has acquired exclusive rights to weight-loss drug orlistat for OTC use in markets outside the U.S., excluding Japan.